The International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma
The International Myeloma Working Group recommends the implementation of these criteria in routine practice and in future clinical trials, and recommends that future studies analyse any differences in outcome that might occur as a result of the new disease definition.
Donna D. Catamero
ANP-BC, OCN, CCRC
Associate Director, Multiple Myeloma Research Program
Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
The International Myeloma Working Group developed practical recommendations for the diagnosis and management of multiple myeloma-related renal impairment (RI)....
2022 Update on Multiple Myeloma Diagnosis, Risk Stratification, and Management
Imaging modalities for multiple myeloma (MM) patient management are explored, highlighting advantages, disadvantages, and applications of each. Imaging is instrumental in detecting intramedullary and extramedullary disease, providing prognostic information, and...
National Institutes of Health (NIH) estimates new cases of multiple myeloma (MM) for 2022, and the projections were made by the American Cancer Society (ACS), based on earlier reported data....